Regulatory T Cells Promote Glioma Cell Stemness Through TGF-β–NF-κB–IL6–STAT3 Signaling
Shasha Liu,Chaoqi Zhang,Boqiao Wang,Huanyu Zhang,Guohui Qin,Congcong Li,Ling Cao,Qun Gao,Yu Ping,Kai Zhang,Jingyao Lian,Qitai Zhao,Dan Wang,Zhen Zhang,Xuan Zhao,Li Yang,Lan Huang,Bo Yang,Yi Zhang
DOI: https://doi.org/10.1007/s00262-021-02872-0
IF: 6.63
2021-01-01
Cancer Immunology Immunotherapy
Abstract:Glioma stem cells (GSCs) contribute to the malignant growth of glioma, but little is known about the interaction between GSCs and tumor microenvironment. Here, we found that intense infiltration of regulatory T cells (Tregs) facilitated the qualities of GSCs through TGF-beta secretion that helped coordinately tumor growth. Mechanistic investigations indicated that TGF-beta acted on cancer cells to induce the core cancer stem cell-related genes CD133, SOX2, NESTIN, MUSASHI1 and ALDH1A expression and spheres formation via NF-kappa B-IL6-STAT3 signaling pathway, resulting in the increased cancer stemness and tumorigenic potential. Furthermore, Tregs promoted glioma tumor growth, and this effect could be abrogated with blockade of IL6 receptor by tocilizumab which also demonstrated certain level of therapeutic efficacy in xenograft model. Additionally, expression levels of CD133, IL6 and TGF-beta were found to serve as prognosis markers of glioma patients. Collectively, our findings reveal a new immune-associated mechanism underlying Tregs-induced GSCs. Moreover, efforts to target this network may be an effective strategy for treating glioma.